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Background/aim: Adenoid hypertrophy (AH) is one of the most frequent pediatric disorders. The aim of this study was to investigate
the effects of TLR2-R753Q, TLR4-T399I, and TLR4-D299G polymorphisms in children with AH.
Materials and methods: The variants of the TLR gene were determined by restriction fragment length polymorphism (PCR-RFLP)
analysis in 60 patients with AH and in 50 healthy children. Data were analyzed with SNPStats and multifactor dimensionality reduction
(MDR) software.
Results: We found that the presence of the G allele, the AG+GG and AG genotypes at TLR4-D299G, and the GGT haplotype were
associated with AH in children (P = 0.013, P = 0.02, P = 0.038, and P = 0.001, respectively). On the contrary, no association was found
between TLR2-R753Q and predisposition to AH. The CT genotype at TLR4-T399I showed a sex-specific association with AH, occurring
only in boys with allergies (P = 0.0048). In addition, MDR analysis indicated a strong synergy between TLR gene markers contributing
to AH. Allergic children with the diplotypes that included minor alleles of TLR4-D299G or TLR4-T399I had about a 4-fold increased
risk for AH.
Conclusion: Common genetic variants of the gene encoding the TLR4 protein may have differential effects on AH and the presence of
sex-specific allergy.
Key words: Adenoid hypertrophy, allergy, TLR2-R753Q, TLR4-D299G, TLR4-T399I, polymorphism, PCR-RFLP

1. Introduction
Adenoid hypertrophy (AH) is one of the most common
pediatric otorhinolaryngological disorders and it is usually
accompanied by recurrent acute tonsillitis and tonsillar
hypertrophy (1,2). Adenoids are immune organs active
at mainly between 3 and 10 years of age (1,3). Recurrent
or chronic inflammation of the adenoids leads to chronic
activation of the cell-mediated and humoral immune
response resulting in AH. AH causes significant clinical
symptoms related to the obstruction of the upper airway,
including snoring, sleep apnea, nasal congestion, and
hyponasal speech (4,5). Identifying the factors that affect
the immunological response would provide important
data to explain the pathogenesis of AH.
Toll-like receptors (TLRs) play an integral role in the
regulation of the immune system through the recognition
of pathogen-associated molecular patterns and activation
of immune response genes (6). TLR2 and TLR4 have
been well studied (7,8). They initiate intracellular signal
* Correspondence: s_unurlu@yahoo.com

cascades that involve adaptor proteins and they lead to
interferon production (9).
Three single nucleotide polymorphisms (SNPs),
TLR2 (2258 A>G) (corresponding to an Arg753Gln
substitution mutation; SNP database [dbSNP] accession
number rs5743708), TLR4 (896 A>G) (corresponding
to an Asp299Gly substitution mutation; dbSNP
accession number rs4986790), and TLR4 (1196 C>T)
(corresponding to a Thr399Ile substitution mutation;
dbSNP accession number rs4986791), have been shown
to be associated with receptor hyporesponsiveness and
immunopathology (10). There has been great interest
regarding the association of these SNPs with susceptibility
to infectious and noninfectious disease states (11–13).
However, the possible contribution of those SNPs to AH
is not yet known.
In this study, we aimed to reassess the association of
TLR2-R753Q, TLR4-D299G, and TLR4-T399I and their
combinations with susceptibility to AH using odds ratios
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(ORs), which can elucidate the magnitude and association
of individual genotypes.
2. Materials and methods
2.1. Study population
One hundred and ten subjects aged between 3 and 10 years
(24 girls and 36 boys; age range 3–7 years; mean ± standard
deviation [SD] 4.81 ± 1.2) who were admitted to the ear,
nose, and throat clinic of the Yenimahalle Education and
Research Hospital, Ankara, Turkey, between January and
August 2015 were included in the study. The child’s parents
or accompanying relatives Figure provided their verbal
and written informed consent for inclusion in the study.
The study protocol was approved by the Dışkapı Education
and Research Hospital’s Ethics Committee (registration
number 2015-008), and the study was conducted in
accordance with human rights and experimental ethics.
2.1.1. Children with AH
Sixty children with symptoms of sleeping with their
mouths open, mouth breathing, snoring, witnessed
apnea, hyponasal speech, malnutrition, and midfacial
developmental disorders who were admitted to the hospital,
diagnosed with AH, and scheduled for adenoidectomy
were included in the study. AH diagnosis was made with
a characteristic history and physical examination findings,
including nasal endoscopy, and confirmed with lateral
cephalometric X-ray findings (13,14). AH was graded
according to Parikh’s classification: grade 1 indicated
adenoid tissue not in contact with adjacent structures;
grade 2 indicated adenoid tissue in contact with the tubal
orifice; grade 3 indicated adenoid tissue in contact with
the vomer; and grade 4 indicated adenoid tissue in contact
with the soft palate (13).
The diagnosis of sleep-disordered breathing (SDB)
was primarily based on physical examination and medical
history of the patients obtained from the parents or the
guardians of the child (15,16). They filled in an established

and validated asthma and allergy questionnaire (ISAAC)
(17), and they were asked whether they had a diagnosis of
asthma or allergic bronchitis by a physician, or a history
of wheezing.
2.1.2. Healthy children
The control group consisted of 50 healthy children who
had presented to the outpatient clinic for regular followup or minor trauma. An endoscopic examination was
performed, and the diagnosis of AH was ruled out in these
children. All children and their parents were evaluated
for the presence of asthma, allergies, and SDB using
questionnaires.
A personal and family history of immune deficiency
or diseases with known immune-related etiologies,
craniofacial abnormalities, congenital defects, or mental
retardation; cardiovascular, pulmonary, or metabolic
diseases; and genetic and neuromuscular diseases served
as exclusion criteria in this study (18).
2.2. Identification of genetic variants of the TLR
Blood samples were obtained from the participants after
they provided their informed consent. The blood samples
were put into tubes containing EDTA. A standard kit was
used in accordance with the manufacturer’s instructions
for genomic DNA extraction from the peripheral blood
samples (NucleoSpin blood DNA; Macherey-Nagel
GmbH & Co. Kg, Düren, Germany). Polymorphisms were
detected using allele-specific PCR, followed by restriction
fragment length polymorphism (PCR-RFLP) analysis.
All primers are summarized in Table 1. Primers for the
detection of the TLR4-D299G SNP and TLR4-T399I
SNPs were forward 3’ and cut point 5’. The nucleotides in
parentheses were modified and changed to the underlined
ones.
For detection of the TLR2-R753Q polymorphism, the
protocol was designed on the basis of the fact that the
polymorphism results in the creation of a DNA sequence
recognized by the restriction enzyme SfcI (New England

Table 1. The primers used for PCR-RFLP.
Polymorphism

Location

TLR2-R753Q

2258 G>A

TLR4-D299G

896 A>G

TLR4-T399I

1196 C>T

Primer nucleotide sequence (5-3)
F- ATGGTCCAGGAGCTGGAGA
R- TGACATAAAGATCCCAACTAGACAA
F- ATTAGCATACTTAGACTACTACCTC(G)CATG
R- GATCAACTTCTGAAAAAGCATTCCCAC
F- GGTTGCTGTTCTCAAAGTGATTTTGGGA(C)GAA
R- GATCAACTTCTGAAAAAGCATTCCCAC

F = Forward primer; R = reverse primer, bp = base pairs.
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Product size (bp)
430
249
408
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BioLabs, Ipswich, MA, USA) (19). The PCR conditions
were 2 min at 94 °C, followed by 38 cycles at 94 °C for 30 s,
64 °C for 30 s, and 72 °C for 45 s with 5 min at 72 °C after
the last cycle. The presence of undigested PCR products
(430 bp) was indicative of wild-type samples, whereas the
presence of the polymorphism resulted in the digestion of
the PCR products to 307-bp and 123-bp fragments.
Molecular detection of the TLR4-D299G and TLR4T399I SNPs was done using PCR-RFLP (20,21). In brief,
the forward primers were modified at the 5’ end in
two reactions, creating restriction enzyme recognition
sites (NcoI for the TLR4-D299G polymorphism and
HinfI for the TLR4-T399I polymorphism), so that if a
polymorphism was present, PCR-RFLP analysis would
create digestion fragments visible on agarose gels (20,21).
The conditions of both PCRs were 5 min at 94 °C, followed
by 38 cycles of 94 °C for 30 s, 61 °C for 30 s, and 72 °C for
60 s with 5 min at 72 °C after the last cycle. For the TLR4D299G SNP, a 249-bp fragment was amplified by PCR and
subjected to NcoI digestion (Invitrogen, Carlsbad, CA,
USA) overnight at 37 °C. The presence of undigested PCR
products was indicative of wild-type samples, whereas the
presence of the polymorphism resulted in the digestion
of the PCR products to 226-bp and 23-bp fragments. For
the TLR4-T399I SNP, a 408-bp fragment was amplified
by PCR and subjected to HinfI digestion (FastDigest;
Thermo Fisher Scientific, Waltham, MA, USA) for 4 h
at 37 °C. The presence of undigested PCR products was
indicative of wild-type samples, whereas the presence of
the polymorphism resulted in the digestion of the PCR
products to 378-bp and 29-bp fragments.
For all PCRs described here, a total of 2 µL (20–50 ng/µL)
of DNA was amplified in a 25-µL reaction mixture using,
2.5 µL of 10X buffer (Complete; Bioron Inc., Ludwigshafen,
Germany), 0.5 µL of 10 mM deoxynucleoside triphosphate,
0.5 µL of 20 pmol of each primer, 2.5 µL of 25 mM MgCl2,
0.2 µL (1.0 U) of Taq polymerase (Invitrogen), and 16
µL of dH2O in a buffer supplied by the manufacturer.
All PCR and digestion procedures were carried out in
a PCR thermal cycler (T100 Thermal Cycler; Bio-Rad,
Hercules, CA, USA), and the PCR and digestion products
were analyzed in 2% Tris-borate-EDTA agarose gels. For
confirmation of the PCR-RFLP analysis results, randomly
chosen PCR products positive and negative for the TLR
polymorphisms were purified by use of a kit (NucleoFast
96 PCR; Macherey-Nagel GmbH & Co.), and they were
directly sequenced using an ABI PRISM 3130 Genetic
Analyzer (Applied Biosystems, Foster City, CA, USA)
and a sequencing kit (BigDye Terminator V3.1 Cycle
Sequencing; Applied Biosystems).
2.3. Statistical analysis
Statistical analyses were performed using SPSS 16.0 (SPSS
Inc., Chicago, IL, USA). A nonparametric Mann–Whitney

U test was used to compare age. Pearson’s chi-square
test was used to assess the differences for the alleles and
genotypes.
The frequency of each genotype was evaluated using
SNPStats software (http://bioinfo.iconcologia.net/index.
php?module=Snpstats) for concordance with Hardy–
Weinberg equilibrium (HWE) (22). Moreover, the
degree of pair-wise linkage disequilibrium (LD) and the
genotype and haplotype analyses were conducted using
regression in this logistic model and expressed as the OR
and 95% confidence interval (95% CI) (23). We used the
Multifactor Dimensionality Reduction (MDR) software
package (version 1.0.0, available at www.epistasis.org)
to construct all possible interactions among different
genotype variants belonging to the TLR gene (24). MDR
is a novel computational tool described by Hahn et al.,
and it is a nonparametric method (i.e. no parameters are
estimated). It can detect SNP × SNP and SNP × phenotype
interactions (25,26). P < 0.05 was considered statistically
significant.
3. Results
3.1. Characteristics of subjects
A total of 60 children with AH (24 girls, 36 boys; age range
3–7 years) and 50 healthy children (22 girls, 28 boys; age
range 3–10 years) without AH were included in this study.
The demographic characteristics of the children with AH
and the controls are shown in Table 2. The mean age of the
children with AH was 4.79 ± 1.097 years and the mean age
of the control children was 4.84 ± 1.394 years (P = 0.680).
Sex distribution was similar in the two groups (P = 0.065).
SDB, asthma, and allergy prevalences were higher in
children with AH than in the controls (62%, 27%, 37% and
P = 0.001, P = 0.042, P = 0.045, respectively). In addition,
68 (71%) patients had an AH grade of 3, and 27 (29%) had
an AH grade greater than 3. AH grades of 4 and 3 were
more frequently seen than AH grades of 2 and 1 (25%,
55%, 12%, 8% for AH grades 4, 3, 2, and 1, respectively;
P = 0.001).
3.2. Association of the TLR genotypes with AH and
phenotypes
All genotype distributions of the control subjects were
consistent with those expected from HWE (all P = 1)
(Table 3). Three SNPs were screened in healthy children
and the children with AH. Genotype analysis revealed that
TLR2-R753Q GA (0.03 vs. 0.02) and TLR4-T399I CT (0.12
vs. 0.06) genotypes were more frequent in children with
AH than in healthy children in the codominant model (P
= 0.06 and P = 0.30). In addition, the difference between
children with AH and controls were significant in the
G-dominant all-inheritance model (AG + GG vs. GG) of
the TLR4-D299G genotype (all P > 0.05). When the minor
allele frequency of the TLR4-D299G was considered,
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Table 2. The demographic characteristics of the children.
Variables

Children with AH (n: 60)
n (%)

Controls (n: 50)
n (%)

P-value

Age (years) (mean ± SD)

4.79 [0.993]

4.84 [1.419]

0.68*

Sex M/F

36 (60) / 24 (40)

28 (56) / 22 (44)

0.654**

1

5 (8)

0 (0)

2

7 (12)

0 (0)

3

15 (25)

0 (0)

4

33 (55)

0 (0)

SDB (+)

37 (62)

5 (10)

0.001**

Asthma (+)

16 (27)

9 (18)

0.042**

Allergy (+)

22 (37)

10 (20)

0.045**

AH grade

<0.0001**

SD = Standard deviation; n (%) = frequency; AH = adenoid hypertrophy; SDB = sleep-disordered breathing.
The data are presented as mean ± SD or numbers (%) unless otherwise specified.
*Mann–Whitney U test. ** χ2 test.
Table 3. The TLR gene polymorphisms.

Polymorphism

SNP ID

Locus

Region

Allele
change

Allele

TLR2-R753Q

rs5743708

2258

Exon3

[G/A]

TLR4-D299G

rs4986790

896

Exon3

TLR4-T399I

rs4986791

1196

Exon3

MAF
AH

Control

*Database

**Turkey

***P for
HWE

Genotyped
(%)

A

0.02

0.01

0.00–0.052

0.0539–0.0240

1

97

[A/G]

G

0.08

0.01

0.00–0.076

36

0.027

1

92

[C/T]

T

0.06

0.03

0.00–0.152

0.02736

1

91

AH: Adenoid hypertrophy; SNP ID = single-nucleotide polymorphism accession number or NCBI dbSNP (http:www.ncbi.nlm.nih.govsnp); MAF = minor allele frequencies;
HWE = Hardy–Weinberg equilibrium.
*Minimum–maximum MAF values from the HapMap databases (http:www.hapmap.org) or NCBI dbSNP (http:www.ncbi.nlm.nih.govsnp).
**MAF from healthy control groups in independent studies on Turkish population.
***HWE P-value in the controls.

significant differences were observed between children
with AH and the controls (for TLR4-D299G: 7.5% and 1%,
P = 0.013; for TLR2-R753Q: 1.7% and 1%, P = 0.67; for
TLR4-T399I: 5.8% and 3%, P = 0.30) (Table 4).
Allergic children within the G-log additive model for
TLR4-D299G and allergic boys within the T-dominant
inheritance codominant model for TLR4-T399I were
more frequent among children with AH than those with
other genotypes (adjusted OR, 3.87; 95% CI, 1.07–13.95; P
= 0.0034 and adjusted OR, 7.86; 95% CI, 1.77–34.89; P =
0.0048, respectively).
Moreover, SDB in the G-dominant all-inheritance
models (except for recessive TLR4-D299G) and the
T-dominant inheritance codominant model for TLR4T399I were associated with a significantly increased risk of
AH when compared to those with the other genotypes (for
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codominant: adjusted OR, 5.66; 95% CI, 1.08–29.51; P =
0.031; for dominant: adjusted OR, 6.60; 95% CI, 1.30–33.49;
P = 0.011; for overdominant: adjusted OR, 5.66; 95% CI,
1.08–29.51; P = 0.031; for log-addictive: adjusted OR, 5.50;
95% CI, 1.06–28.67; P = 0.028; adjusted OR, 6.06; 95% CI,
1.25–29.42; P = 0.0089; and for codominant at TLR4-T399I:
adjusted OR, 18.27; 95% CI, 2.22–150.34; P = 0.0089).
There was a tendency towards a higher AH grade in
AH patients carrying the AG genotype at TLR4-D299G
and the CT genotype at TLR4-T399I (OR, 3.29; 95% CI,
1.83–4.74; P = 0.55 and OR, 0.67; 95% CI, 0.11–1.23; P =
0.190, respectively).
The frequencies of GGT and AAC haplotypes were
significantly higher in the AH cases than in the controls
(OR, ∞; 95% CI, 0.00–∞, P = 0.0001) (TLR2 and TLR4,
three SNPs were ordered from 5’ to 3’). The frequencies of
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Table 4. Frequencies of TLR SNP genotype and alleles.

SNPs

Children with AH (n: 60)

Controls (n: 50)

n (%)

n (%)

GG

58 (97)

49 (98)

GA

2 (3)

1 (2)

AA

0 (0)

0 (0)

Aǂ

0.017

0.010

1.68 (0.15–18.78)

AA

52 (87)

49 (98)

1.00 (reference)

AG

7 (11)

1 (2)

GG

1 (2)

0 (0)

AA

52 (87)

49 (98)

AG-GG

8 (13)

1 (2)

AA-AG

59 (98)

50 (100)

GG

1 (2)

0 (0)

AA-GG

53 (88)

49 (98)

AG

7 (11)

1 (2)

---

---

---

Gǂ

0.075

0.010

CC

53 (88)

47 (94)

CT

7 (12)

3 (6)

TT

0 (0)

0 (0)

Tǂ

0.058

0.030

Genotype/allele

TLR2-R753Q

TLR4-D299G

TLR4-T399I

Models

Adjusted OR (95% CI)*

P-value**

1.00 (reference)
Codominant

Codominant

0.58 (0.05–6.66)

0.066

0.00 (0.00–NA)

0.15 (0.02–1.28)

0.67

0.05

0.00 (0.00–NA)
Dominant

Recessive

Overdominant

Log-addictive

1.00 (reference)
0.13 (0.02–1.10)
1.00 (reference)
0.00 (0.00–NA)
1.00 (reference)

0.02

0.27
0.038

0.15 (0.02–1.30)
0.14 (0.02–1.15)

0.017

8.03 (1.00–64.48)

0.013

1.00 (reference)
Codominant

0.48 (0.12–1.98)

0.30

0.00 (0.00–NA)
2.00 (0.50–7.96)

0.30

n (%) = Frequency; NA = not analyzed; SNP = single nucleotide polymorphism; AH = adenoid hypertrophy; OR = odds ratio; CI = confidence interval.
ǂ Assumed risk alleles; *Adjusted for age and sex; ** χ2 test.

Table 5. Associations between AH risk and frequencies of haplotypes based on TLR variants.

No

Haplotypes*

Haplotype frequencies

Cure OR (95% CI)**

***P-value

0.96

1.00 (reference)

---

0.0429

0.01

0.27 (0.03–2.13)

0.22

T

0.0263

0.02

0.68 (0.11–4.29)

0.69

G

T

0.0321

0.00

0.00 (–Inf to Inf)

<0.001

A

C

0.0167

0.00

0.00 (–Inf to Inf)

<0.001

TLR2-R753Q

TLR4-D299G

TLR4-T399I

Patients

Controls

1

G

A

C

0.8821

2

G

G

C

3

G

A

4

G

5

A

AH = Adenoid hypertrophy; OR = odds ratio; CI = confidence interval; Inf = infinity.
*The alleles of haplotypes were genotyped as the location of in the SNPs TLR2 and TLR4.
**In logistic regression model.
***Global haplotype association P-value = 0.12
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GGT in cases with SDB were significantly higher than in
the controls (OR, 2.11; 95% CI, 0.32–3.90; P = 0.023). The
frequency of the AAC haplotype was significantly higher
in the allergic AH cases than in the allergic controls (OR,
14.73; 95% CI, 1.56–139.23; P = 0.001). Moreover, TLR4D299G and TLR4-T399I had a high level of LD (D = 0.88,
r2 = 0.35).
3.3. MDR analyses
MDR software was used to analyze the interaction of the
SNPs and phenotypes that might affect AH. At the end
of the analysis, we found four predictive models for AH.
TLR4-D299G was the best single-locus predictive model,
and the AG and GG genotypes were significantly associated
with the diagnosis of AH [testing balance accuracy (TBA):
0.556 and cross-validation consistency (CVC): 10/10] (for
AG: OR, 7.5 and for GG: OR, ∞, 95% CI, 0.90–62.50; P =
0.0308).
According to the best two-locus predictive model
(TLR2-R753Q_TLR4-D299G), children carrying the GA +
AA, GG + AG, and GG + GG diplotypes showed a TBA of
56.5% and a CVC of 9/10 for prediction of risk of AH (for
GA + AA: OR, 7.5; for GG + AG: OR, 7; and for GG + GG:
OR, ∞, 95% CI, 0.99–23.04; P = 0.0338).
The three-locus model (TLR2-R753Q_TLR4-D299G_
TLR4-T399I) was the third best attribute for prediction
of AH risk, having a TBA of 64.4% and a CVC of 10/10,
which were statistically significant (for GG + AA + CC:
OR, 1.02; for GG + AA + CT: OR, 1.5; for GG + AG + CC:
OR, 3; for GG + AG + CT and GA + GG + CC: OR, ∞, 95%
CI, 1.15–16.20; P = 0.020).
In addition, the individuals with the combination of
TLR4-D299G and TLR4-T399I as well as allergies were
in the high-risk group. The dendrograms provided by
MDR were examined to assist in the visualization and
interpretation of potential genotype × genotype and
genotype × phenotype interactions (Figure 1A) (27). The
dendrogram demonstrated the nature of the interactions
between TLR4-D299G and TLR4-T399I, and the
synergistic association of allergies with those three factors
for predicting susceptibility to AH. As observed in the
dendrogram, TLR4-D299G and allergy fit in one cluster,
while T399I fits in another cluster (Figure 1B) (TBA 0.573,
CVC 9/10, OR 4.88, CI 1.80–13.25, P = 0.001).
4. Discussion
In this study, we investigated the potential associations of
the frequent polymorphisms of the TLR gene with AH,
and their relationships with phenotypes. To the best of our
knowledge, this is the first study presenting associations
between the TLR gene and AH in Turkey. Data analysis
demonstrated that TLR4 polymorphisms were associated
with an increased risk of AH, but it appeared that there was
no association between TLR2-R753Q and a predisposition
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to AH. However, the presence of the CT genotype at TLR4T399I seemed to cause susceptibility to allergies in boys
with AH.
TLRs, together with the interleukin-1 receptors, are a
class of proteins known as the interleukin-1 receptor/TLR
superfamily and play important roles in the initiation and
maintenance of immune responses (6). Numerous studies
have implicated TLRs in the pathogenesis of infectious and
noninfectious disease states (10–12).
Lorenz et al. (28) were the first to report that a genetic
variant at the C terminus of the TLR2 gene was associated
with infection. The SNP TLR2-R753Q sequence change
causes an arginine-to-glutamine substitution at residue
753 of the protein. The amino acid is conserved among
species, and it is a part of highly conserved stretch of amino
acids at TLR2. In addition, in vitro functional analysis
demonstrated that the SNP affected the signaling function
of the molecule. This missense mutation decreased the
ability to respond to infectious agents (28). Thus, TLR2R753Q leads to decreased NF-kB and cellular activation
(28,29). However, in the present study, the minor allele
and all genotypes of TLR2-R753Q were not associated with
AH.
The TLR4-knockout mouse model was shown to be
lipopolysaccharide-hyporesponsive (8). Similarly, two
common mutations identified in the TLR4 gene receptor at
residues 299 and 399 affected the extracellular domain of
the protein and were shown to be associated with receptor
hyporesponsiveness in macrophages, epithelial cells, and
peripheral blood mononuclear cells (30). TLR4 missense
mutations might act in concert with other genetic changes
to influence the complex immunologic response; they may
also be modifying factors for AH and other phenotypes,
and particularly for allergies and asthma (4). Recently it was
shown that TLR4 mutations are linked to an increased risk
of recurrent tonsillitis and/or tonsillar hypertrophy (31).
The adenoids are similar to tonsils, and they are important
components of the lymphoid tissue situated in the upper
airways, known as Waldeyer’s ring (1). Therefore, tonsillar
hypertrophy is usually accompanied by hypertrophy of the
adenoids (2). In our study, children carrying the G allele
at TLR4-D299G had a significantly increased risk for AH.
On the contrary, we found no association between TLR4T399I and a predisposition to AH. As in vitro studies have
shown, TLR4-D299G might have a greater functional
impact on the receptor rather than TLR4-T399I, and this
may be a possible reason for this result (30).
Factors such as obesity, asthma, and allergies are
etiologic contributors and comorbidities of pediatric
SDB (32). However, AH is the most pervasive primary
etiology of SDB (33). In the present study, children with
SDB carrying the minor alleles of TLR4-D299G and TLR4T399I had about 5.50- to 18.27-fold increased risk for
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Figure 1. Distribution of the TLR4-D299G and TLR4-T399I genotype and allergy combinations in cases and controls according to MDR.
A) The TLR4-D299G and TLR4-T399I genotype and allergy combinations that are able to correctly predict AH with an accuracy of
64.3%. The TLR4 GG+CC, AA+CC, and AG+CT genotypes had ∞-fold, 2.6-fold, and ∞-fold increased risk for allergic AH, respectively.
For each genotype combination, the numbers of allergic or nonallergic cases are displayed in the histogram on the left in each cell, while
the numbers of allergic or nonallergic controls are displayed in the histogram on the right. A darker shade indicates the high-risk group.
The pattern of high- and low-risk for the presence of AH differs depending on the presence of the allergy and value of TLR4-D299G and
TLR4-T399I (TBA 0.573, CVC 9/10, OR 4.88, CI 1.80–13.25, P = 0.001). B) The dendrogram demonstrates the nature of the interactions
between the TLR4-D299G/TLR4-T399I genotype and allergy included in the genetic classifier obtained by MDR. There was a synergistic
interaction, with the strongest interaction between TLR4-D299G and allergy.

AH. Therefore, similar genotypes and haplotypes were
associated with AH and SDB and unsurprisingly showed
the role of the TLR gene in the molecular mechanisms
underlying AH.
The role of allergies in promoting chronic inflammation
associated with AH remains unclear in children (5,33). A

number of studies showed that TLR4 SNPs were associated
with childhood allergies and/or asthma (34,35). Similarly,
recent studies conducted on Turkish children harboring
heterozygous TLR4 polymorphisms reported a relation
of those polymorphisms with asthma and atopic asthma
(36,37). In the present study, we showed that presence of
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the minor alleles of TLR4-D299G and TLR4-T399I and the
AAC haplotype were associated with an increased (3.87, 7.86-, and 15-fold) risk of allergic AH. We also showed
that this association was sex-specific, as it was stronger
in boys with the TLR4-T399I CT genotype. Interestingly,
the allergic children carrying minor alleles TLR4-D299G
and TLR4-T399I had about a 4-fold increased risk of AH,
as indicated with MDR analysis. However, we did not
find any significant association between asthma and TLR
gene polymorphisms in the Turkish population studied.
These findings indicated complex interactions between
TLR4 gene variations and susceptibility to allergic AH.
They also indicated that AH and allergies probably have
a shared genetic background, since they have common
pathways with several immunological processes that could
be further modified by genetic variations in other innate
immune response genes (38).
In the haplotype analysis, we found that the GGT
haplotype was frequent in AH cases, and it was associated
with AH in the studied population. Notably, the LD
between TLR4-D299G and TLR4-T399I was stronger,
consistent with previously reported data (HapMap,
accessible at http://hapmap.ncbi.nlm.nih.gov/). In the
current study, we also used a data mining approach: MDR
reduces data dimensionality by pooling genotypes from
multiple SNPs into either high-risk or low-risk groups
for a disease, thereby circumventing the problem of
high-order genotype combinations with a low number of
observations. It has successfully identified combinations of
multilocus genotypes and discrete environmental factors
that are associated with some complex diseases (24–26).
Via the interaction information analysis, we have shown
for the first time a strong synergism between the TLR
gene markers contributing to AH in a Turkish population.
Furthermore, our MDR results showed that the main
effects of the logistic regression model or other traditional
approaches might not be observed (the 1 + 1 = 3 principle)

(25). Thus, the haplotype findings, as well as LD and MDR
analysis, are consistent with each other in the present study,
providing an insight into possible interactions between
TLR gene polymorphisms and susceptibility to AH.
The minor allele frequencies of TLR gene
polymorphisms have been reported in international webbased databases among different populations (http:www.
hapmap.org and http:www.ncbi.nlm.nih.govsnp). The
minor allele frequencies of the TLR gene found in healthy
controls in the present study were similar to previous studies
performed in Turkish populations, but the prevalence rates
were different from the ones reported in different regions
of the world (36,37,39,40). Those discrepancies may be due
to sample size, ethnic background, or geographic region,
and they may affect the results of the genetic association
studies (41).
One of the potential limitations of our study is that it
is a hospital-based cohort including only Turkish children.
Another important limitation is the relatively small
sample size, which may notably affect the results (42). For
this reason, our findings need to be replicated in further
studies with larger-scale population-based studies in
different populations.
In conclusion, our findings indicated that TLR4 gene
polymorphisms predisposed individuals to AH and
allergic AH. Those genetic variations might lead to an
alteration in the inflammatory cascade that could regulate
AH pathophysiology. Further studies with a larger sample
size and a more representative population should be
performed to verify our results.
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